InvestorsHub Logo
Followers 1
Posts 12
Boards Moderated 0
Alias Born 09/29/2018

Re: None

Saturday, 01/22/2022 5:46:25 PM

Saturday, January 22, 2022 5:46:25 PM

Post# of 426476
Matinas update on Lypdiso. Also note recent press release on oral form of Remdesivir-GS 5245.
Gilead also in NASH study i.e. Vascepa. FWIW getting interesting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News